Distribusi Benign Soft Tissue Tumor berdasarkan Gender dan Usia
Keywords:
Benign Soft Tissue Tumor, Gender, AgeAbstract
Soft tissue tumor is a disorder that occurs in non-epithelial tissue including fatty tissue, fibrous tissue, neurovascular tissue and muscle tissue. This disease is more common in women than men. While the age that is often diagnosed with this lesion is found in the age range of 15-25 years and 35-54 years. This study aims to analyze whether there is an influence between gender and age with the distribution of benign soft tissue tumors. This study uses a cross sectional study with a retrospective approach. The research sample was histopathological preparations taken from 161 patients with medical record data according to the inclusion criteria. Sampling using purposive sampling technique. Data were analyzed using fisher test. Based on gender, the highest frequency of samples was female as much as 51.6%. Based on age, it was found more in the age range of 17-25 years. The results of the chi-square test of the effect of gender on the distribution of benign soft tissue tumors showed p 1.000, while the effect of age on the distribution of benign soft tissue tumors showed p 0.407. There is no significant effect between the distribution of benign soft tissue tumors on gender and age.
References
[2] R. Magetsari and D. Agustian, “Epidemiology of Musculoskeletal Tumors in Sardjito Hospital Yogyakarta Indonesia,” Edorium J Med, vol. 4, pp. 1–7, 2018, doi: 10.5348/100005M05RM2018OA.
[3] J. H. Choi and J. Y. Ro, “The 2020 WHO Classification of Tumors of Soft Tissue: Selected Changes and New Entities,” Adv. Anat. Pathol., vol. 28, no. 1, pp. 44–58, 2021, doi: 10.1097/PAP.0000000000000284.
[4] Surveillance Epidemiology and End Results, “Cancer Stat Facts: Soft Tissue including Heart Cancer,” 2021. https://seer.cancer.gov/statfacts/html/soft.html.
[5] Badan Penelitian dan Pengembangan Kesehatan, “Laporan Nasional Riskesdas 2018,” Badan Penelitian dan Pengembangan Kesehatan. p. 198, 2018.
[6] L. R. Sadykova et al., “Epidemiology and Risk Factors of Osteosarcoma,” Cancer Invest., vol. 38, no. 5, pp. 259–269, 2020, doi: 10.1080/07357907.2020.1768401.
[7] R. Oemiati, E. Rahajeng, and A. Yudi Kristanto, “Prevalensi Tumor Dan Beberapa Faktor Yang Mempengaruhinya Di Indonesia,” Bul. Penelit. Kesehat., vol. 39, no. 4, pp. 190–204, 2011.
[8] J. A. Pangkahila, “Pengaturan Pola Hidup Dan Aktivitas Fisik Meningkatkan Umur Harapan Hidup,” Sport Fit. J., vol. 1, pp. 1–7, 2013.
[9] I. Masturo and N. A. T, “Metodelogi Penelitian Kesehatan.” BADAN PENGEMBANGAN DAN PEMBERDAYAAN SUMBER DAYA MANUSIA KESEHATAN, 2018.
[10] M. Ikhsan, A. Budi, and I. Handriani, “Faktor Resiko dan Karakteristik Infantil Hemangioma di RSUD Dr. Soetomo Tahun 2015 - 2019,” J. Rekonstruksi dan Estet., vol. 6, no. 1, p. 25, 2021, doi: 10.20473/jre.v6i1.28229.
[11] C. B. Tenedero, K. Oei, and M. R. Palmert, “An Approach to the Evaluation and Management of The Obese Child With Early Puberty,” J. Endocr. Soc., vol. 6, no. 1, pp. 1–11, 2021, doi: 10.1016/j.ehmc.2014.03.004.
[12] Y. Ding, J. Z. Zhang, S. R. Yu, F. Xiang, and X. J. Kang, “Risk Factors for Infantile Hemangioma: A Meta-Analysis,” World J. Pediatr., vol. 16, no. 4, pp. 377–384, 2019, doi: 10.1007/s12519-019-00327-2.
[13] C. J. F. Smith, S. F. Friedlander, M. Guma, A. Kavanaugh, and C. D. Chambers, “Infantile Hemangiomas: An Updated Review on Risk Factors, Pathogenesis, and Treatment,” Physiol. Behav., vol. 176, no. 1, pp. 100–106, 2018, doi: 10.1002/bdr2.1023.Infantile.
[14] M. Yajun, W. Shan, and F. Qihong, “New Progress in Clinical Treatment of Infantile Hemangioma,” vol. 10, no. 5, pp. 355–365, 2021.
[15] D. M. M. Granados, M. B. De Baptista, L. C. Bonadia, C. S. Bertuzzo, and C. E. Steiner, “Clinical and Molecular Investigation of Familial Multiple Lipomatosis: Variants in The HMGA2 Gene,” Clin. Cosmet. Investig. Dermatol., vol. 13, pp. 1–10, 2020, doi: 10.2147/CCID.S213139.
[16] K. Choi et al., “An Inflammatory Gene Signature Distinguishes Neurofibroma Schwann cells and Macrophages from Cells in The Normal Peripheral Nervous System,” Sci. Rep., vol. 7, no. January, pp. 1–14, 2017, doi: 10.1038/srep43315.
[17] A. K. Eisfeld et al., “NF1 Mutations Are Recurrent in Adult Acute Myeloid Leukemia and Confer Poor Outcome,” Leukemia, vol. 32, no. 12, pp. 2536–2545, 2018, doi: 10.1038/s41375-018-0147-4.
[18] S. R. Plotkin and A. Wick, “Neurofibromatosis and Schwannomatosis,” vol. 38, pp. 73–85, 2018.
[19] S. Bachir et al., “Neurofibromatosis Type 2 (NF2) and The Implications for Vestibular Schwannoma and Meningioma Pathogenesis,” Int. J. Mol. Sci., vol. 22, no. 2, pp. 1–12, 2021, doi: 10.3390/ijms22020690.
[20] S. R. Edwards and M. F. Gilheany, “Spindle Cell Lipoma of The Foot,” Foot Ankle Surg. Tech. Reports Cases, vol. 1, no. 3, p. 100043, 2021, doi: 10.1016/j.fastrc.2021.100043.
[21] Q. FENG, X. CAI, Y. CAI, G. ZHANG, J. LIAN, and L. ZHU, “Multiple Symmetric Lipomas: A Case Report,” Chinese J. Plast. Reconstr. Surg., vol. 2, no. 4, pp. 257–262, 2020, doi: 10.1016/s2096-6911(21)00046-7.
[22] A. Murayama, T. Kuroda, A. Shudo, and Y. Kang, “A Case of Symmetric Lipomatosis of The Tongue Arising in A Patient with Alcoholic Liver Cirrhosis Presenting with Macroglossia,” Oral Sci. Int., vol. 18, no. 1, pp. 94–98, 2021, doi: 10.1002/osi2.1083.
Downloads
Published
How to Cite
Issue
Section
License
Copyright (c) 2022 Tri Kurnia Ahmad Islamuddin, Yuni Prastyo Kurniati
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
